Peptide-MHC-based nanovaccines for the treatment of autoimmunity: A "one size fits all" approach?

Journal of Molecular Medicine

Volumn 89, Issue 8, 2011, Pages 733-742

  Clemente Casares, Xavier ^a   Tsai, Sue ^a   Yang, Yang ^a   Santamaria, Pere ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Autoimmunity; Beta cells; Diabetes; Immune tolerance; Lymphocyte

Indexed keywords

GLUTAMATE DECARBOXYLASE 65[217-236]; GLUTAMATE DECARBOXYLASE 65[290-309] I A G7 IMMUNOGLOBULIN G 2A DIMER; ISLET SPECIFIC GLUCOSE 6 PHOSPHATASE CATALYTIC SUBUNIT RELATED PROTEIN[206-214]; MYELIN BASIC PROTEIN[84-102] DR2; MYELIN BASIC PROTEIN[85-99] DR2 IMMUNOGLOBULIN G DIMER; MYELIN OLIGODENDROCYTE GLYCOPROTEIN[35-55] RECOMBINANT T CELL RECEPTOR LIGAND; PEPTIDE MAJOR HISTOCOMPATIBILITY COMPLEX 1 NANOVACCINE; PEPTIDE MAJOR HISTOCOMPATIBILITY COMPLEX 2 NANOVACCINE; PEPTIDE VACCINE; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ARTICLE; AUTOIMMUNE DISEASE; DIABETES MELLITUS; DRUG RESEARCH; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; NANOTECHNOLOGY; NONHUMAN; RHEUMATOID ARTHRITIS;

ANIMALS; AUTOIMMUNE DISEASES; AUTOIMMUNITY; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; NANOPARTICLES; PEPTIDES; VACCINES;

EID: 80052479923     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-011-0757-z     Document Type: Article

References (59)

1. MK Jenkins DM Pardoll J Mizuguchi H Quill RH Schwartz 1987 T-cell unresponsiveness in vivo and in vitro: fine specificity of induction and molecular characterization of the unresponsive state Immunol Rev 95 113 135 2437012 10.1111/j.1600-065X.1987.tb00502.x 1:CAS:528:DyaL2sXhvFCitbo%3D (Pubitemid 17027899)
2. SD Sharma B Nag XM Su D Green E Spack BR Clark S Sriram 1991 Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes Proc Natl Acad Sci USA 88 11465 11469 1722335 10.1073/pnas.88.24.11465 1:CAS:528: DyaK38Xlslahuw%3D%3D (Pubitemid 21916062)
3. B Nag T Kendrick S Arimilli SC Yu S Sriram 1996 Soluble MHC II-peptide complexes induce antigen-specific apoptosis in T cells Cell Immunol 170 25 33 10.1006/cimm.1996.0130 8660796 10.1006/cimm.1996.0130 1:CAS:528: DyaK28XjtlaitLg%3D
4. B Nag S Arimilli PV Mukku I Astafieva 1996 Functionally active recombinant alpha and beta chain-peptide complexes of human major histocompatibility class II molecules J Biol Chem 271 10413 10418 8626615 10.1074/jbc.271.17.10413 1:CAS:528:DyaK28XisFKjtr8%3D (Pubitemid 26131608)
5. S Arimilli JB Mumm B Nag 1996 Antigen-specific apoptosis in immortalized T cells by soluble MHC class II-peptide complexes Immunol Cell Biol 74 96 104 10.1038/icb.1996.13 8934660 10.1038/icb.1996.13 1:CAS:528:DyaK28XislGqurs%3D (Pubitemid 26150505)
6. DE Goodkin M Shulman J Winkelhake E Waubant P Andersson T Stewart S Nelson N Fischbein PK Coyle E Frohman L Jacobs J Holcenberg M Lee S Mocci 2000 A phase I trial of solubilized DR2:MBP84-102 (AG284) in multiple sclerosis Neurology 54 1414 1420 10751249 1:CAS:528:DC%2BD3cXivFOitLc%3D (Pubitemid 30210458)
7. MW Nicolle A Vincent S Sharma B Nag N Willcox J Newsom-Davis 1993 An in vitro model for disease-specific immunotherapy in myasthenia gravis using soluble MHC class II bound to AChR-derived peptide Ann NY Acad Sci 681 577 580 8357203 10.1111/j.1749-6632.1993.tb22946.x 1:CAS:528:DyaK3sXlsFyju74%3D (Pubitemid 23233883)
8. MW Nicolle B Nag SD Sharma N Willcox A Vincent DJ Ferguson J Newsom-Davis 1994 Specific tolerance to an acetylcholine receptor epitope induced in vitro in myasthenia gravis CD4+ lymphocytes by soluble major histocompatibility complex class II-peptide complexes J Clin Invest 93 1361 1369 10.1172/JCI117112 7512979 10.1172/JCI117112 1:CAS:528:DyaK2cXis1yjtbc%3D
9. AP Bond L Corlett SJ Curnow E Spack N Willcox J Newsom-Davis 1998 Diverse patterns of unresponsiveness in an acetylcholine receptor-specific T-cell clone from a myasthenia gravis patient after engaging the T-cell receptor with three different ligands J Neuroimmunol 82 182 190 9585815 10.1016/S0165-5728(97)00202- 6 1:CAS:528:DyaK1cXhvFKisL4%3D (Pubitemid 28179921)
10. EG Spack M McCutcheon N Corbelletta B Nag D Passmore SD Sharma 1995 Induction of tolerance in experimental autoimmune myasthenia gravis with solubilized MHC class II:acetylcholine receptor peptide complexes J Autoimmun 8 787 807 8824707 10.1016/S0896-8411(95)80018-2 1:STN:280:DyaK28vit1Sqsg%3D%3D (Pubitemid 26046547)
11. A Kavanaugh M Genovese J Baughman A Kivitz K Bulpitt N Olsen M Weisman E Matteson D Furst R van Vollenhoven J Anderson S Cohen N Wei J Meijerink C Jacobs S Mocci 2003 Allele and antigen-specific treatment of rheumatoid arthritis: a double blind, placebo controlled phase 1 trial J Rheumatol 30 449 454 12610799 1:CAS:528:DC%2BD3sXisVKgsr8%3D (Pubitemid 36301932)
12. H Groux A O'Garra M Bigler M Rouleau S Antonenko JE de Vries MG Roncarolo 1997 A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis Nature 389 737 742 10.1038/39614 9338786 10.1038/39614 1:CAS:528:DyaK2sXmvVSgtb0%3D (Pubitemid 27458961)
13. AM Thornton EM Shevach 1998 CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production J Exp Med 188 287 296 9670041 10.1084/jem.188.2.287 1:CAS:528:DyaK1cXkvVaqt7g%3D (Pubitemid 28357757)
14. GG Burrows BF Bebo Jr KL Adlard AA Vandenbark H Offner 1998 Two-domain MHC class II molecules form stable complexes with myelin basic protein 69-89 peptide that detect and inhibit rat encephalitogenic T cells and treat experimental autoimmune encephalomyelitis J Immunol 161 5987 5996 9834080 1:CAS:528:DyaK1cXnslCrsbk%3D (Pubitemid 28535967)
15. GG Burrows JW Chang HP Bachinger DN Bourdette H Offner AA Vandenbark 1999 Design, engineering and production of functional single-chain T cell receptor ligands Protein Eng 12 771 778 10506287 10.1093/protein/12.9.771 1:CAS:528:DyaK1MXmvVagtro%3D (Pubitemid 29472084)
16. GG Burrows KL Adlard BF Bebo Jr JW Chang K Tenditnyy AA Vandenbark H Offner 2000 Regulation of encephalitogenic T cells with recombinant TCR ligands J Immunol 164 6366 6371 10843691 1:CAS:528:DC%2BD3cXktFWlt7k%3D (Pubitemid 30408818)
17. S Sinha S Subramanian L Miller TM Proctor C Roberts GG Burrows AA Vandenbark H Offner 2009 Cytokine switch and bystander suppression of autoimmune responses to multiple antigens in experimental autoimmune encephalomyelitis by a single recombinant T-cell receptor ligand J Neurosci 29 3816 3823 10.1523/JNEUROSCI.5812-08.2009 19321778 10.1523/JNEUROSCI.5812-08.2009 1:CAS:528:DC%2BD1MXktVSqtLY%3D
18. C Wang BG Gold LJ Kaler X Yu ME Afentoulis GG Burrows AA Vandenbark DN Bourdette H Offner 2006 Antigen-specific therapy promotes repair of myelin and axonal damage in established EAE J Neurochem 98 1817 1827 10.1111/j.1471-4159. 2006.04081.x 16899071 10.1111/j.1471-4159.2006.04081.x 1:CAS:528: DC%2BD28XhtVCksb7M (Pubitemid 44313640)
19. H Offner S Subramanian C Wang M Afentoulis AA Vandenbark J Huan GG Burrows 2005 Treatment of passive experimental autoimmune encephalomyelitis in SJL mice with a recombinant TCR ligand induces IL-13 and prevents axonal injury J Immunol 175 4103 4111 16148160 1:CAS:528:DC%2BD2MXpslCltrc%3D (Pubitemid 41292074)
20. J Huan S Subramanian R Jones C Rich J Link J Mooney DN Bourdette AA Vandenbark GG Burrows H Offner 2004 Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch J Immunol 172 4556 4566 15034073 1:CAS:528:DC%2BD2cXitlOqtbw%3D (Pubitemid 38375273)
21. JM Link CM Rich M Korat GG Burrows H Offner AA Vandenbark 2007 Monomeric DR2/MOG-35-55 recombinant TCR ligand treats relapses of experimental encephalomyelitis in DR2 transgenic mice Clin Immunol 123 95 104 10.1016/j.clim.2006.12.002 17257899 10.1016/j.clim.2006.12.002 1:CAS:528:DC%2BD2sXjtValtbo%3D (Pubitemid 46401509)
22. AA Vandenbark C Rich J Mooney A Zamora C Wang J Huan L Fugger H Offner R Jones GG Burrows 2003 Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice J Immunol 171 127 133 12816990 1:CAS:528: DC%2BD3sXks12jtr4%3D (Pubitemid 36745280)
23. S Sinha S Subramanian TM Proctor LJ Kaler M Grafe R Dahan J Huan AA Vandenbark GG Burrows H Offner 2007 A promising therapeutic approach for multiple sclerosis: recombinant T-cell receptor ligands modulate experimental autoimmune encephalomyelitis by reducing interleukin-17 production and inhibiting migration of encephalitogenic cells into the CNS J Neurosci 27 12531 12539 10.1523/JNEUROSCI.3599-07.2007 18003831 10.1523/JNEUROSCI.3599-07.2007 1:CAS:528:DC%2BD2sXhsVSgs7fM (Pubitemid 350127826)
24. S Sinha S Subramanian A Emerson-Webber M Lindner GG Burrows M Grafe C Linington AA Vandenbark CC Bernard H Offner 2010 Recombinant TCR ligand reverses clinical signs and CNS damage of EAE induced by recombinant human MOG J Neuroimmune Pharmacol 5 231 239 10.1007/s11481-009-9175-1 19789980 10.1007/s11481-009-9175-1
25. V Yadav D Bourdette JD Bowen SG Lynch D Mattson J Preiningerova C Rose RB Stead AJ Ferro AS Goldstein GG Burrows H Offner AA Vandenbark 2010 Recombinant T cell receptor ligand (RTL) for the treatment of multiple sclerosis: report of a phase I clinical trial Neurology 74 A293 A294
26. H Offner S Sinha GG Burrows AJ Ferro AA Vandenbark 2010 RTL therapy for multiple sclerosis: a phase I clinical study J Neuroimmunol 10.1016/j.jneuroim. 2010.09.013
27. G Adamus GG Burrows AA Vandenbark H Offner 2006 Treatment of autoimmune anterior uveitis with recombinant TCR ligands Invest Ophthalmol Vis Sci 47 2555 2561 10.1167/iovs.05-1242 16723470 10.1167/iovs.05-1242 (Pubitemid 351639841)
28. G Adamus LJ Karren J Mooney GG Burrows 2010 A promising therapeutic approach for treatment of posterior uveitis: recombinant T cell receptor ligand protects Lewis rats from acute and recurrent experimental autoimmune uveitis Ophthalmic Res 44 24 33 10.1159/000281815 20145422 10.1159/000281815 1:CAS:528:DC%2BC3cXntFSisbg%3D
29. J Huan LJ Kaler JL Mooney S Subramanian C Hopke AA Vandenbark EF Rosloniec GG Burrows H Offner 2008 MHC class II derived recombinant T cell receptor ligands protect DBA/1LacJ mice from collagen-induced arthritis J Immunol 180 1249 1257 18178865 1:CAS:528:DC%2BD1cXhsVOqug%3D%3D
30. J Huan R Meza-Romero JL Mooney AA Vandenbark H Offner GG Burrows 2010 Single-chain recombinant HLA-DQ2.5/peptide molecules block alpha2-gliadin- specific pathogenic CD4(+) T-cell proliferation and attenuate production of inflammatory cytokines: a potential therapy for celiac disease Mucosal Immunol 10.1038/mi.2010.44 20736999
31. AP Fontenot TS Keizer M McCleskey DG Mack R Meza-Romero J Huan DM Edwards YK Chou AA Vandenbark B Scott GG Burrows 2006 Recombinant HLA-DP2 binds beryllium and tolerizes beryllium-specific pathogenic CD4+ T cells J Immunol 177 3874 3883 16951350 1:CAS:528:DC%2BD28XptlOgsLo%3D (Pubitemid 44359922)
32. S Subramanian B Zhang Y Kosaka GG Burrows MR Grafe AA Vandenbark PD Hurn H Offner 2009 Recombinant T cell receptor ligand treats experimental stroke Stroke 40 2539 2545 10.1161/STROKEAHA.108.543991 19443805 10.1161/STROKEAHA.108. 543991 1:CAS:528:DC%2BD1MXnsFyjuro%3D
33. J McCluskey R Blok L Kjer-Nielsen 1989 The role of major histocompatibility molecules in antigen-specific immune responses Transplant Proc 21 591 594 2495622 1:CAS:528:DyaL1MXkt1WksLY%3D (Pubitemid 19118134)
34. JP Abastado YC Lone A Casrouge G Boulot P Kourilsky 1995 Dimerization of soluble major histocompatibility complex-peptide complexes is sufficient for activation of T cell hybridoma and induction of unresponsiveness J Exp Med 182 439 447 7629504 10.1084/jem.182.2.439 1:CAS:528:DyaK2MXntFKhs7Y%3D
35. SH Herrmann MF Mescher 1986 The requirements for antigen multivalency in class I antigen recognition and triggering of primed precursor cytolytic T lymphocytes J Immunol 136 2816 2825 3082973 1:CAS:528:DyaL28XitVGisro%3D (Pubitemid 16107182)
36. SM O'Herrin JE Slansky Q Tang MA Markiewicz TF Gajewski DM Pardoll JP Schneck JA Bluestone 2001 Antigen-specific blockade of T cells in vivo using dimeric MHC peptide J Immunol 167 2555 2560 11509595 (Pubitemid 32768882)
37. S Tsai A Shameli J Yamanouchi X Clemente-Casares J Wang P Serra Y Yang Z Medarova A Moore P Santamaria 2010 Reversal of autoimmunity by boosting memory-like autoregulatory T cells Immunity 32 568 580 10.1016/j.immuni.2010.03. 015 20381385 10.1016/j.immuni.2010.03.015 1:CAS:528:DC%2BC3cXlslSisrw%3D
38. L Zuo CM Cullen ML DeLay S Thornton LK Myers EF Rosloniec GP Boivin R Hirsch 2002 A single-chain class II MHC-IgG3 fusion protein inhibits autoimmune arthritis by induction of antigen-specific hyporesponsiveness J Immunol 168 2554 2559 11859151 1:CAS:528:DC%2BD38XhvVegtr0%3D (Pubitemid 34171864)
39. H Appel NP Seth L Gauthier KW Wucherpfennig 2001 Anergy induction by dimeric TCR ligands J Immunol 166 5279 5285 11290814 1:CAS:528: DC%2BD3MXivVKmtr8%3D (Pubitemid 32280746)
40. S Casares A Hurtado RC McEvoy A Sarukhan H von Boehmer TD Brumeanu 2002 Down-regulation of diabetogenic CD4+ T cells by a soluble dimeric peptide-MHC class II chimera Nat Immunol 3 383 391 10.1038/ni770ni770 11862219 10.1038/ni770 1:CAS:528:DC%2BD38Xis1Kktr4%3D (Pubitemid 34308627)
41. S Casares M Lin N Zhang JR Teijaro C Stoica R McEvoy DL Farber C Bona TD Brumeanu 2008 A peptide-major histocompatibility complex II chimera favors survival of pancreatic beta-islets grafted in type 1 diabetic mice Transplantation 85 1717 1725 10.1097/TP.0b013e31817752cc00007890-200806270-00007 18580462 10.1097/TP.0b013e31817752cc 1:CAS:528:DC%2BD1cXns1Ogt7k%3D
42. I Preda RC McEvoy M Lin CA Bona R Rapaport TD Brumeanu S Casares 2005 Soluble, dimeric HLA DR4-peptide chimeras: an approach for detection and immunoregulation of human type-1 diabetes Eur J Immunol 35 2762 2775 10.1002/eji.200526158 16106371 10.1002/eji.200526158 1:CAS:528: DC%2BD2MXhtVOqsL3E (Pubitemid 41404059)
43. M Lin C Stoica-Nazarov J Surls M Kehl C Bona C Olsen TD Brumeanu S Casares 2010 Reversal of type 1 diabetes by a new MHC II-peptide chimera: "Single-epitope-mediated suppression" to stabilize a polyclonal autoimmune T-cell process Eur J Immunol 40 2277 2288 10.1002/eji.200940094 20540111 10.1002/eji.200940094 1:CAS:528:DC%2BC3cXpsF2rsLg%3D
44. EL Masteller MR Warner W Ferlin V Judkowski D Wilson N Glaichenhaus JA Bluestone 2003 Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes J Immunol 171 5587 5595 14607967 1:CAS:528:DC%2BD3sXoslyhs7c%3D (Pubitemid 37432850)
45. L Li Z Yi B Wang R Tisch 2009 Suppression of ongoing T cell-mediated autoimmunity by peptide-MHC class II dimer vaccination J Immunol 183 4809 4816 19752238 10.4049/jimmunol.0901616 1:CAS:528:DC%2BD1MXhtFGjsLrM
46. S Lieberman T DiLorenzo 2003 A comprehensive guide to antibody and T-cell responses in type 1 diabetes Tissue Antigens 62 359 377 14617043 10.1034/j.1399-0039.2003.00152.x 1:CAS:528:DC%2BD3sXpsVOiurw%3D (Pubitemid 37338877)
47. S Tsai A Shameli P Santamaria 2008 CD8+ T-cells in autoimmune diabetes Adv Immunol 100 79 124 19111164 10.1016/S0065-2776(08)00804-3 1:CAS:528:DC%2BD1MXpsFeis78%3D
48. M Nakayama N Abiru H Moriyama N Babaya E Liu D Miao L Yu DR Wegmann JC Hutton JF Elliott GS Eisenbarth 2005 Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice Nature 435 220 223 15889095 10.1038/nature03523 1:CAS:528:DC%2BD2MXktVWhtLg%3D (Pubitemid 40685949)
49. Y Fan WA Rudert M Grupillo J He G Sisino M Trucco 2009 Thymus-specific deletion of insulin induces autoimmune diabetes EMBO J 28 2812 2824 19680229 10.1038/emboj.2009.212 1:CAS:528:DC%2BD1MXpsFKgtLo%3D
50. P Santamaria 2010 The long and winding road to understanding and conquering type 1 diabetes Immunity 32 437 445 20412754 10.1016/j.immuni.2010. 04.003 1:CAS:528:DC%2BC3cXlslSjurY%3D
51. B Han P Serra A Amrani J Yamanouchi AF Maree L Edelstein-Keshet P Santamaria 2005 Prevention of diabetes by manipulation of anti-IGRP autoimmunity: high efficiency of a low-affinity peptide Nat Med 11 645 652 10.1038/nm1250 15908957 10.1038/nm1250 1:CAS:528:DC%2BD2MXkslOksLw%3D (Pubitemid 40868305)
52. J Wang S Tsai A Shameli J Yamanouchi G Alkemade P Santamaria 2010 In situ recognition of autoantigen as an essential gatekeeper in autoimmune inflammation Proc Natl Acad Sci USA 107 20 9317 9322 20439719 10.1073/pnas.0913835107 1:CAS:528:DC%2BC3cXmslGrtbo%3D
53. S Lieberman T Takaki B Han P Santamaria D Serreze T DiLorenzo 2004 Individual nonobese diabetic mice exhibit unique patterns of CD8+ T cell reactivity to three islet antigens, including the newly identified widely expressed dystrophia myotonica kinase J Immunol 173 6727 6734 15557165 1:CAS:528:DC%2BD2cXhtVShsb%2FM (Pubitemid 39541058)
54. A Amrani J Verdaguer P Serra S Tafuro R Tan P Santamaria 2000 Progression of autoimmune diabetes driven by avidity maturation of a T-cell population Nature 406 739 742 10.1038/35021081 10963600 10.1038/35021081 1:CAS:528:DC%2BD3cXmt1Cgur4%3D
55. P Aichele D Kyburz P Ohashi B Odermatt R Zinkernagel H Hengartner H Pircher 1994 Peptide-induced T-cell tolerance to prevent autoimmune diabetes in a transgenic mouse model Proc Natl Acad Sci USA 91 444 448 8290546 10.1073/pnas.91.2.444 1:CAS:528:DyaK2cXhs1WntLo%3D (Pubitemid 24041418)
56. R Toes R Offringa R Blom C Melief W Kast 1996 Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction Proc Natl Acad Sci USA 93 7855 7860 8755566 10.1073/pnas.93.15.7855 1:CAS:528:DyaK28XksFSrtLw%3D (Pubitemid 26277128)
57. J Yamanouchi J Verdaguer B Han A Amrani P Serra P Santamaria 2003 Cross-priming of diabetogenic T cells dissociated from CTL-induced shedding of beta cell autoantigens J Immunol 171 6900 6909 14662897 1:CAS:528: DC%2BD3sXpsV2ruro%3D (Pubitemid 37532126)
58. H Jiang L Chess 2009 How the immune system achieves self-nonself discrimination during adaptive immunity Adv Immunol 102 95 133 19477320 10.1016/S0065-2776(09)01202-4 1:CAS:528:DC%2BD1MXhtVSnsbjP
59. O Sangkon L Perera D Burke T Waldmann J Berzofsky 2004 IL-15/IL-15Ra-mediated avidity maturation of memory CD8+ T cells Proc Natl Acad Sci USA 101 15154 15159 10.1073/pnas.0406649101 (Pubitemid 39391734)